| Previous Close | 1.0100 |
| Open | 0.9900 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.9500 - 1.0700 |
| 52 Week Range | 0.0280 - 1.3100 |
| Volume | |
| Avg. Volume | 37,879 |
| Market Cap | 2.253M |
| Beta (5Y Monthly) | 2.41 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ISTANBUL, Turkey, April 28, 2023 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp.‘s (OTC: PRTT) (“Company”) President Ali Yildiz addresses the Company’s shareholders with a corporate update on expansion and forward-looking progress. The Company has entered into new shipment route agreements throughout the Black Sea. These new routes open-up vast opportunities throughout the region and provide a very consistent growth opportunity for the Company. These routes range from product transportation to
Istanbul, Turkey, April 10, 2023 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. “OTC:(PRTT)” announces the completion of the recent appointment of Ali Yildiz as President and the finalization of the acquisition of Antarax Capital Danismanlik Limited. With the filing of the new company financials on the OTC Markets website, this completes the initial introduction of an enhanced Protect Pharmaceutical Corp. to our shareholders and the public markets. The company President Mr. Yildiz has been inv
Istanbul, Turkey, March 08, 2023 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. “OTC:(PRTT)” announces the change of control of the Preferred series A shares and the appointment of a new president, Ali Yildiz. Aetsoft, as previously announced, has been divested from the company. Mr. Yildiz brings a wealth of knowledge and experience to the company. Mr. Yildiz has an impressive track record growing companies on a large scale and is looking forward to bringing his skill to create growth and stab
Cheyenne, Wyoming, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corporation, Inc. (OTC:PRTT) informs, that the Share Exchange Agreement №1, signed on June 15, 2022 was not executed due to the insufficiency of legal instruments on the territory of the Republic of Belarus for conducting such transactions, and terminated on December 6, 2022. The absence of an established agreement between the US and Belarus depositories and the lack of a legal basis for conducting transactions on the in
Cheyenne, Wyoming, June 27, 2022 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corporation (OTC:PRTT) has acquired the 100% of the shares of CJSC “Inaiapp”, a Belarusian developer of corporate software for business digitalization. With 8 years of blockchain development experience and list of long term clients, Inaiapp will bring its qualification and management processes to a new level. “Robotic process automation, AI systems and machine learning systems, blockchain-based solutions, Data Science to
After many months of strategic planning and development, the two companies are ready to announce the details of their upcoming acquisition deal. Minsk, Belarus., June 23, 2022 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corporation, Inc. “OTC:(PRTT)” will enter into a share exchange agreement with СJSC “Inaiapp” (a leading blockchain solutions provider in EU region) in order to secure its strategic goals for the web 3.0 market. The agreement is to acquire 100% of the outstanding shares of Inaiapp